Hendrik Treede*, Ardawan Rastan, Markus Ferrari, Stephan Ensminger, Hans Reiner Figulla, Friedrich Wilhelm Mohr

*Corresponding author for this work
30 Citations (Scopus)


The JenaValve™ is a next-generation TAVI device which consists of a well-proven porcine root valve mounted on a low-profile nitinol stent. Feeler guided positioning and clip fixation on the diseased leaflets allow for anatomically correct implantation of the device without rapid pacing. Safety and efficacy of transapical aortic valve implantation using the JenaValveo were evaluated in a multicentre prospective study that showed good short and midterm results. The valve was CE-mark released in Europe in September 2011. A post-market registry ensures on-going and prospective data collection in "real-world" patients. The transfemoral JenaValveo delivery system will be evaluated in a first-in-man study in the near future.

Original languageEnglish
Pages (from-to)Q88-Q93
Publication statusPublished - 2012


Dive into the research topics of 'JenaValve'. Together they form a unique fingerprint.

Cite this